Allison Florance

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer

Stephen Johnston, John Pippen, Xavier Pivot et al. · Journal of Clinical Oncology · 2009 · 1K citations · Full text

Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study

Kimberly Blackwell, Harold J. Burstein, Anna Maria Storniolo et al. · Journal of Clinical Oncology · 2012 · 541 citations

Large Scale Implementation of a Respiratory Therapist– driven Protocol for Ventilator Weaning

E. Wesley Ely, PATRICIA A. BENNETT, DAVID L. BOWTON et al. · American Journal of Respiratory and Critical Care Medicine · 1999 · 300 citations

Lapatinib plus Letrozole as First-Line Therapy for HER-2+ Hormone Receptor–Positive Metastatic Breast Cancer

Lee S. Schwartzberg, Sandra Franco, Allison Florance et al. · The Oncologist · 2010 · 189 citations · Full text

A randomized study of lapatinib alone or in combination with trastuzumab in heavily pretreated HER2+ metastatic breast cancer progressing on trastuzumab therapy

J. O’Shaughnessy, K. L. Blackwell, Harold J. Burstein et al. · Journal of Clinical Oncology · 2008 · 157 citations

Breast Oncology, Immunology, Pathology +18